Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
收藏官方服务：
资源简介：
To assess safety and immunogenicity of an affordable egg-based recombinant Newcastle disease virus vaccine (NDV-HXP-S) expressing the spike (S) protein of SARS-CoV-2
提供机构：
ImmPort创建时间：
2022-12-19
